A 52-year-old woman from urban Delhi attends a community health camp organized under NPCDCS. Random blood glucose is 186 mg/dL, and she reports a 2-year history of polyuria and polydipsia. Fasting blood glucose on repeat testing is 128 mg/dL. She is overweight (BMI 28 kg/m²), has a sedentary lifestyle, and a family history of diabetes in her mother. She denies any current symptoms of hyperglycemia. According to NPCDCS screening and diagnostic criteria, what is her current status and the recommended first-line intervention?

Explanation

## Diagnostic Criteria for Diabetes Under NPCDCS **Key Point:** NPCDCS adopts WHO/ADA diagnostic criteria. A diagnosis of Type 2 diabetes is established when ANY of the following are met: - Fasting plasma glucose ≥126 mg/dL (≥7.0 mmol/L) - Random plasma glucose ≥200 mg/dL (≥11.1 mmol/L) WITH symptoms of hyperglycemia - 2-hour plasma glucose ≥200 mg/dL during OGTT ## Analysis of This Patient's Presentation **High-Yield:** This patient's random blood glucose is **186 mg/dL** — this does NOT meet the diagnostic threshold of ≥200 mg/dL required for diagnosis based on random glucose (even with symptoms). Therefore, the diagnosis rests solely on the **fasting blood glucose of 128 mg/dL**, which is ≥126 mg/dL and is diagnostic of Type 2 Diabetes Mellitus. **Clinical Pearl:** A single fasting glucose ≥126 mg/dL is sufficient for diagnosis when confirmed on repeat testing (as done here). The random glucose of 186 mg/dL, while elevated, cannot independently confirm diabetes in the absence of a value ≥200 mg/dL. ## NPCDCS First-Line Management Strategy | Step | Recommendation | |------|---------------| | Step 1 | **Lifestyle modification** (diet, physical activity, weight management) | | Step 2 | Reassess at **3 months** | | Step 3 | If glycemic targets not met → add Metformin | **Clinical Pearl:** According to NPCDCS guidelines (and consistent with WHO/IDF recommendations for newly diagnosed T2DM), **lifestyle modification is the recommended first-line intervention** in newly diagnosed Type 2 DM, particularly when the patient is not severely hyperglycemic (no HbA1c >9%, no symptoms of severe hyperglycemia, no ketosis). Pharmacotherapy (metformin) is initiated if lifestyle modification fails to achieve glycemic targets after a defined period (typically 3 months). ## Why Option C Is Correct | Criterion | This Patient's Status | |-----------|----------------------| | Fasting glucose | 128 mg/dL (≥126 mg/dL: Diagnostic) | | Random glucose | 186 mg/dL (<200 mg/dL: NOT independently diagnostic) | | Symptoms | Polyuria/polydipsia present, but RBG criterion not met | | Diagnosis | **Newly diagnosed Type 2 Diabetes Mellitus** (based on FBG ≥126 mg/dL) | | First-line intervention | **Lifestyle modification + repeat testing in 2 weeks** | ## Why Other Options Are Incorrect - **Option A (Prediabetes; acarbose):** Incorrect — FBG 128 mg/dL exceeds the prediabetes range (100–125 mg/dL); acarbose is not NPCDCS first-line. - **Option B (Impaired fasting glucose; lifestyle):** Incorrect — IFG is defined as FBG 100–125 mg/dL; this patient's FBG of 128 mg/dL is diagnostic of diabetes, not IFG. - **Option D (Immediate metformin):** Incorrect — NPCDCS guidelines recommend lifestyle modification as the initial step in newly diagnosed T2DM without severe hyperglycemia; immediate pharmacotherapy without a lifestyle trial is not the recommended first-line approach per NPCDCS stepwise protocol. **Reference:** NPCDCS Operational Guidelines (MoHFW, India); WHO Diagnostic Criteria for Diabetes; Park's Textbook of Preventive and Social Medicine, 26th edition.